Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG‐fusion positive and PTEN deleted prostate cancers

18 Sept 2015

Abstract excerpt

Zinc-alpha 2-glycoprotein (AZGP1) is involved in lipid metabolism and was suggested as a candidate prognostic biomarker in prostate cancer. To evaluate the clinical impact and relationship with key genomic alterations in prostate cancer, AZGP1 expression was analyzed by immunohistochemistry on a tissue microarray containing 11,152 prostate cancers. Data on ERG status and PTEN, 3p13, 5q21 and 6q15 deletions were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Molecular Biology Techniques and Applications
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26383228
DOI: 10.1002/ijc.29860

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG‐fusion positive and PTEN deleted prostate cancersPMID 26383228Read ↗

AZGP1 is androgen responsive and involved in AR‐induced prostate cancer cell proliferation and metastasisSemantic proximity Read ↗

Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.Semantic proximity Read ↗

Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate CancerSemantic proximity Read ↗

Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer.Semantic proximity Read ↗

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceSemantic proximity Read ↗

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancerSemantic proximity Read ↗

The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer BiomarkerSemantic proximity Read ↗

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancerSemantic proximity Read ↗

ERG Protein Expression and Gene Rearrangements Are Present at Lower Rates in Metastatic and Locally Advanced Castration-resistant Prostate Cancer Compared to Localized DiseaseSemantic proximity Read ↗

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsSemantic proximity Read ↗

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerSemantic proximity Read ↗

Detection of<i>ERG</i>gene rearrangements and<i>PTEN</i>deletions in unsuspected prostate cancer of the transition zoneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.